{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:27:07Z","timestamp":1778884027075,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.euroneuro.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T03:18:56Z","timestamp":1366687136000},"page":"1806-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: Molecular and behavioral aspects"],"prefix":"10.1016","volume":"23","author":[{"given":"Itzhak","family":"Levi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Eskira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnon","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiftach","family":"Talgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Fanous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuly","family":"Bersudsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RH","family":"Belmaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galila","family":"Agam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orna","family":"Almog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.02.004_bib1","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1073\/pnas.94.4.1488","article-title":"Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene","volume":"94","author":"Airaksinen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-1128(199703)17:2<215::AID-MED3>3.0.CO;2-2","article-title":"Inositol monophosphatase inhibitors\u2014lithium mimetics?","volume":"17","author":"Atack","year":"1997","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(95)00063-F","article-title":"Structure and mechanism of inositol monophosphatase","volume":"361","author":"Atack","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0166-2236(95)93926-O","article-title":"Inositol monophosphatase\u2014a putative target for Li+ in the treatment of bipolar disorder","volume":"18","author":"Atack","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib5","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1523\/JNEUROSCI.23-08-03469.2003","article-title":"Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination","volume":"23","author":"Barski","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0006-3223(02)01360-4","article-title":"Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins","volume":"52","author":"Beasley","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neubiorev.2007.05.001","article-title":"Lithium-pilocarpine seizures as a model for lithium action in mania","volume":"31","author":"Belmaker","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib8","doi-asserted-by":"crossref","first-page":"41954","DOI":"10.1074\/jbc.M203492200","article-title":"Myo-inositol monophosphatase is an activated target of calbindin D28k","volume":"277","author":"Berggard","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib9","doi-asserted-by":"crossref","first-page":"16662","DOI":"10.1074\/jbc.M200415200","article-title":"Calbindin D28k exhibits properties characteristic of a Ca2+ sensor","volume":"277","author":"Berggard","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib10","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jama.1989.03430130110043","article-title":"The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling","volume":"262","author":"Berridge","year":"1989","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj2060587","article-title":"Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands","volume":"206","author":"Berridge","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FBP.0b013e32801416ed","article-title":"Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss","volume":"18","author":"Bersudsky","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0896-6273(03)00196-X","article-title":"Ca2\u00b1 buffer saturation underlies paired pulse facilitation in calbindin-D28k-containing terminals","volume":"38","author":"Blatow","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(90)90091-H","article-title":"Calbindin D-28k and parvalbumin in the rat nervous system","volume":"35","author":"Celio","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0006-3223(01)01243-4","article-title":"The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia","volume":"51","author":"Cotter","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.npp.1301431","article-title":"IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity","volume":"33","author":"Cryns","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib18","series-title":"The PyMOL Molecular Graphics System in","author":"DeLano","year":"2002"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/14756369909036548","article-title":"Inhibitors of inositol monophosphatase","volume":"14","author":"Fauroux","year":"1999","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-8993(81)90067-6","article-title":"Responses to cortical injury: I .Methodology and local effects of contusions in the rat","volume":"211","author":"Feeney","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib21","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0968-0896(98)00148-5","article-title":"Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonates","volume":"6","author":"Ganzhorn","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1107\/S0907444905004038","article-title":"High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy","volume":"61","author":"Gill","year":"2005","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/bip.360310619","article-title":"Backbone cyclization: a new method for conferring conformational constraint on peptides","volume":"31","author":"Gilon","year":"1991","journal-title":"Biopolymers"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/cercor\/11.12.1170","article-title":"The human temporal cortex: characterization of neurons expressing nitric oxide synthase, neuropeptides and calcium-binding proteins, and their glutamate receptor subunit profiles","volume":"11","author":"Gonzalez-Albo","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib26","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1016\/S0021-9258(19)70391-3","article-title":"The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain","volume":"255","author":"Hallcher","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","article-title":"Search for a common mechanism of mood stabilizers","volume":"66","author":"Harwood","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib28","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1021\/jm070836d","article-title":"Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability","volume":"50","author":"Hess","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/jm701093y","article-title":"Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity","volume":"51","author":"Hess","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1440-1789.2001.00393.x","article-title":"Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease","volume":"21","author":"Iritani","year":"2001","journal-title":"Neuropathology"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/jmbi.1999.3053","article-title":"Miniaturized proteins: the backbone cyclic proteinomimetic approach","volume":"292","author":"Kasher","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib32","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1073\/pnas.89.6.2195","article-title":"Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques","volume":"89","author":"Katchalski-Katzir","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/17460441.2010.493935","article-title":"Improvement of drug-like properties of peptides: the somatostatin paradigm","volume":"5","author":"Kessler","year":"2010","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib34","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0006-3223(93)90052-F","article-title":"Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression","volume":"34","author":"Kofman","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nsmb1112","article-title":"Structure, binding interface and hydrophobic transitions of Ca2+-loaded calbindin-D(28K)","volume":"13","author":"Kojetin","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib37","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/sj.emboj.7601186","article-title":"Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport","volume":"25","author":"Lambers","year":"2006","journal-title":"Embo J."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1432-1033.1993.tb17707.x","article-title":"Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+","volume":"212","author":"Leech","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0896-6273(91)90120-O","article-title":"Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons","volume":"6","author":"Mattson","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1096-9861(19971110)388:1<64::AID-CNE5>3.0.CO;2-M","article-title":"Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex","volume":"388","author":"Mikkonen","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib41","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","article-title":"Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium","volume":"24","author":"O'Brien","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1074\/jbc.M604474200","article-title":"Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1","volume":"282","author":"Ohnishi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1012092409216","article-title":"Effect of restricted conformational flexibility on the permeation of model hexapeptides across Caco-2 cell monolayers","volume":"14","author":"Okumu","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bmc.2009.12.010","article-title":"The effect of backbone cyclization on PK\/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm","volume":"18","author":"Ovadia","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1012091014242","article-title":"Esterase-sensitive cyclic prodrugs of peptides: evaluation of a phenylpropionic acid promoiety in a model hexapeptide","volume":"14","author":"Pauletti","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000314310","article-title":"Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects","volume":"62","author":"Quiroz","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/npp.2008.167","article-title":"Protein-protein interactions as therapeutic targets in neuropsychopharmacology","volume":"34","author":"Reilly","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.2001.5783","article-title":"Amino acid sequence requirements of peptides that inhibit polyglutamine-protein aggregation and cell death","volume":"288","author":"Ren","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib49","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1073\/pnas.0407855102","article-title":"Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons","volume":"102","author":"Schmidt","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/15622970109027499","article-title":"Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar, schizophrenic and unipolar patients","volume":"2","author":"Shaltiel","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-5618.2004.00162.x","article-title":"Interaction of calbindin D and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder","volume":"7","author":"Shamir","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib52","doi-asserted-by":"crossref","first-page":"12709","DOI":"10.1021\/bi7008135","article-title":"Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1","volume":"46","author":"Sharma","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib53","doi-asserted-by":"crossref","first-page":"34343","DOI":"10.1074\/jbc.274.48.34343","article-title":"Calbindin-D(28k) controls [Ca2+]i and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines","volume":"274","author":"Sooy","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/prep.1999.1028","article-title":"Expression and purification of human calbindin D28k","volume":"15","author":"Thulin","year":"1999","journal-title":"Protein Expression Purif."},{"key":"10.1016\/j.euroneuro.2013.02.004_bib55","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","article-title":"Reaching for high-hanging fruit in drug discovery at protein-protein interfaces","volume":"450","author":"Wells","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2013.02.004_bib56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/417292a","article-title":"A common mechanism of action for three mood-stabilizing drugs","volume":"417","author":"Williams","year":"2002","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1016\/j.euroneuro.2015.09.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000}}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T16:48:07Z","timestamp":1644857287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924977X13000643"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.02.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: Molecular and behavioral aspects","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}